Page 4,849«..1020..4,8484,8494,8504,851..4,8604,870..»

Arch Therapeutics Co-Founder Dr. Ellis-Behnke to Speak at Nanomanufacturing Summit 2013 in Philadelphia, October 15 …

Posted: Published on October 11th, 2013

WELLESLEY, MA--(Marketwired - Oct 10, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), is pleased to announce that co-founding and inventing scientist, Dr. Rutledge Ellis-Behnke, will be featured during the opening day activities at the Nanomanufacturing Summit 2013 October 15-17, 2013 at the University of Pennsylvania in Philadelphia. Dr. Ellis-Behnke's keynote speech encompasses, "Nanomedicine: discovering, manufacturing and using new Molecular Medical Devices for immediate hemostasis." He will focus on how related new technology, including AC5, should fundamentally alter the practice of medicine and surgery, as well as how material design at the nanoscale can provide desired product properties and characteristics. Ellis-Behnke, comments, "The Nanomanufacturing Summit is a great opportunity for government, universities, industry and business to exchange emergent information on the current status of nanoscale products as well as offering insights into new commercial practices that introduce robust manufacturing techniques with an ability to actually make the leap from the research lab into medical practices across the nation and around the world." Dr. Ellis-Behnke was instrumental in discovering the hemostatic and other barrier properties of self-assembling peptides that could make future surgery and interventional care faster and safer. He proposed the development and commercialization of what became … Continue reading

Comments Off on Arch Therapeutics Co-Founder Dr. Ellis-Behnke to Speak at Nanomanufacturing Summit 2013 in Philadelphia, October 15 …

Cell growth discovery has implications for targeting cancer

Posted: Published on October 11th, 2013

1 hour ago The way cells divide to form new cellsto support growth, to repair damaged tissues, or simply to maintain our healthy adult functioningis controlled in previously unsuspected ways UC San Francisco researchers have discovered. The findings, they said, may lead to new ways to fight cancer. The steps leading a quiet cell to make and divvy up new parts to form daughter cells rely on some of the cell's most complex molecular machines. Different machines play key roles at different stages of this cell cycle. Each of these cellular machines consists of many proteins assembled into a functioning whole. They carry out such tasks as repairing DNA in the newly replicated gene-bearing chromosomes, for instance, or helping pull the chromosomes apart so that they can be allocated to daughter cells. In a study published online on October 10, 2013 in the journal Molecular Cell, UCSF researchers led by molecular biologist Davide Ruggero, PhD, associate professor of urology, and computational biologist Barry Taylor, PhD, assistant professor of epidemiology and biostatistics, found that the production of entire sets of proteins that work together to perform such crucial tasks is ramped up together, all at oncenot due to the transcription of … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Cell growth discovery has implications for targeting cancer

Molly 60 Day Post Stem Cell Treatment #2 of 3 – Video

Posted: Published on October 11th, 2013

Molly 60 Day Post Stem Cell Treatment #2 of 3 Molly 60 Day Post Stem Cell Treatment #3 of 3. By: Thomas Beall … Continue reading

Comments Off on Molly 60 Day Post Stem Cell Treatment #2 of 3 – Video

Retinitis Pigmentosa: Almost normal vision after 12 months treatment – Video

Posted: Published on October 10th, 2013

Retinitis Pigmentosa: Almost normal vision after 12 months treatment For more information, or to book an appointment, please contact us: tel:1-877-737-7876 toll free (Canada and US only) 1-604-737-7876 (International) e-mail: ... By: Weidong Yu … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Retinitis Pigmentosa: Almost normal vision after 12 months treatment – Video

Blind cyclist nearing Penticton

Posted: Published on October 10th, 2013

Injuries have prevented blind cyclist Craig Aucoin from continuing his cross-Canada ride but they did not end his dream. Aucoin and sighted partner Lloyd McLean left St. Johns Nfld. Aug. 4 for a planned 85-day, 8,260-kilometre bicycle tour however separate incidents even before they reached Nova Scotia, curtailed his quest. Since then, Bob MacDonald, who suffers from the same condition (retinitis pigmentosa) which left Aucoin legally blind, has taken up the rear seat on the tandem, recumbent cycle. The terrain in Newfoundland was very challenging, a lot of big hills and it was unfortunate about Craig but it is what it is, said McLean in a recent telephone interview from Suffield, Alta., just east of Calgary. But the trip itself has been great and everywhere we go the response we get from the people is wonderful. But as we get closer to the end and we can feel the end coming, it is exciting and hard to believe how many experiences weve had over the last two months. The pair were preparing for their crossing of the Rocky Mountains and are expecting to be in Penticton for a meet and greet Friday, Oct. 18, at about 9:30 a.m. at Home … Continue reading

Posted in Retinitis Pigmentosa | Comments Off on Blind cyclist nearing Penticton

[Seminar introduction] Stem cell therapy for cerebral palsy – Video

Posted: Published on October 10th, 2013

[Seminar introduction] Stem cell therapy for cerebral palsy Cerebral palsy is a non-treatable neurologic disability where only conservative therapy has been practiced so far. Professor Minyoung Kim will present a brea... By: Choi Chulhee … Continue reading

Comments Off on [Seminar introduction] Stem cell therapy for cerebral palsy – Video

Scientists make potential Alzheimer's breakthrough- Novel stem cell technique may transform liver and pancreatic …

Posted: Published on October 10th, 2013

A team of British scientists has released a major study that could represent a breakthrough in the treatment of human neurological diseases, such as Alzheimer's or Parkinson's. In a study published Wednesday in the journal Science Translational Medicine, the team said that it had halted brain cell death in mice by using a drug-like compound that was injected into the animals' stomachs through a mouth tube. The team induced a neurodegenerative disease caused by abnormal prion proteins -- the nearest model of human disorders that can be found in animals -- before treating one group with the compound. According to the study, the mice who were treated remained free of symptoms like memory loss, impaired reflexes, and limb dragging five weeks later. The treated mice also lived longer than the untreated mice. "We were extremely excited when we saw the treatment stop the disease in its tracks and protect brain cells, restoring some normal behaviours and preventing memory loss in the mice, " lead scientist Giovanna Mallucci told Sky News. The study stresses that human trials have yet to be undertaken, and points out that it could be a decade or more before a medicine for the treatment of human … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Scientists make potential Alzheimer's breakthrough- Novel stem cell technique may transform liver and pancreatic …

New Way to Grow Neural Stem Cells Could Accelerate Therapy Development for Brain Injuries and Diseases

Posted: Published on October 10th, 2013

Durham, NC (PRWEB) October 10, 2013 Researchers have discovered a new, highly efficient way to produce neural stem cells from human pluripotent stem cells that can then go on to form neurons in the brain. The discovery, reported in the current issue of STEM CELLS Translational Medicine, could greatly accelerate the development of new drug and cell therapies for people suffering from brain injuries or disease. Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), show great promise in regenerative medicine due to their ability to be coaxed into becoming different specific types of cells. These cells can theoretically then go on to help the body heal itself by replacing or repairing damaged or dead cells. However, the current methods for inducing neural stem cells involve time-consuming, multiple labor-intensive steps that cannot be easily automated or made GMP (good manufacturing practice) compliant for clinical grade manufacture. In addition, not many of the neural stem cells produced this way can be expanded and coaxed into becoming different neural subtypes specific to the brain regions responsible for controlling different functions. Towards this critical need, we have developed a simple one-step protocol with a … Continue reading

Posted in Stem Cell Human Trials | Comments Off on New Way to Grow Neural Stem Cells Could Accelerate Therapy Development for Brain Injuries and Diseases

Molly 30 Day Post Stem Cell Treatment #2 of 2 – Video

Posted: Published on October 10th, 2013

Molly 30 Day Post Stem Cell Treatment #2 of 2 30 Day post stem cell treatment #2 of 2. By: Thomas Beall … Continue reading

Comments Off on Molly 30 Day Post Stem Cell Treatment #2 of 2 – Video

Molly 90 Day Post Stem Cell Treatment # 3 of 5 – Video

Posted: Published on October 10th, 2013

Molly 90 Day Post Stem Cell Treatment # 3 of 5 Molly 90 Day Post Stem Cell Treatment # 3 of 5. By: Thomas Beall … Continue reading

Comments Off on Molly 90 Day Post Stem Cell Treatment # 3 of 5 – Video

Page 4,849«..1020..4,8484,8494,8504,851..4,8604,870..»